# Editorial: Immunoglobulin Therapy in the 21st Century – the Dark Side of the Moon

**Authors:** Albert Farrugia, Marcella Visentini, Isabella Quinti

PMC · DOI: 10.3389/fimmu.2015.00436 · 2015-08-26

## Full-text entities

- **Genes:** FCGR2C (Fc gamma receptor IIc (gene/pseudogene)) [NCBI Gene 9103] {aka CD32, CD32C, CDW32, FCG2, FCRIIC, FcgammaRIIc}
- **Diseases:** PID (MESH:D000081207), haemolysis (MESH:D006461), MMN (MESH:D000080364), pneumonia (MESH:D011014), autoimmune neuropathies (MESH:D020274), CIDP (MESH:D020277), inflammatory (MESH:D007249), autoimmune (MESH:D001327), CVID (MESH:D017074), GBS (MESH:D020275), idiopathic thrombocytopenic purpura (MESH:D016553), pulmonary infections and damage (MESH:D008171), neuropathies (MESH:D009422), IG (MESH:D016609), infections (MESH:D007239), hypogammaglobulinemic diseases (MESH:D004194)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC4549639